Literature DB >> 12522081

Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.

Tetsuzo Nakayama1, Katsuya Hirano, Yoshinobu Shintani, Junji Nishimura, Akio Nakatsuka, Hirotaka Kuga, Shosuke Takahashi, Hideo Kanaide.   

Abstract

1 Using fura-2 fluorometry of [Ca(2+)](i) in response to thrombin, trypsin and protease-activated receptor activating peptides (PAR-APs), we determined whether trypsin cleaves protease-activated receptor 1 (PAR1) and activates it in the endothelial cells of the porcine aortic valves and human umbilical vein. 2 Once stimulated with thrombin, the subsequent application of trypsin induced a [Ca(2+)](i) elevation similar to that obtained without the preceding stimulation with thrombin in the valvular endothelial cells. However, the preceding stimulation with trypsin abolished the subsequent response to thrombin, but not to bradykinin or substance P. 3 The response to PAR1-AP (SFLLRNP) was significantly (P<0.05) reduced by the preceding stimulation with thrombin and PAR1-AP in the valvular endothelial cells, while, importantly, it remained unaffected by the preceding stimulation with either trypsin or PAR2-AP (SLIGRL). The response to PAR2-AP was reduced by the preceding stimulation with trypsin and PAP2-AP. PAR1-AP attenuated the subsequent responses not only to thrombin and PAR1-AP but also to trypsin and PAR2-AP, while PAR2-AP specifically attenuated the subsequent responses to trypsin and PAR2-AP. 4 In human umbilical vein endothelial cells, a higher affinity PAR1-AP (haPAR1-AP) (Ala-pF-Arg-Cha-HArg-Tyr-NH(2)) specifically attenuated the responses to thrombin but not trypsin. On the other hand, the response to haPAR1-AP was significantly (P<0.05) attenuated by the preceding stimulation with thrombin but not trypsin. 5 In conclusion, trypsin cleaved PAR1 but did not activate it in the endothelial cells. Moreover, the trypsin-cleaved PAR1 was no longer responsive to thrombin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522081      PMCID: PMC1573634          DOI: 10.1038/sj.bjp.0705008

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

Review 1.  Protease-activated receptors: sentries for inflammation?

Authors:  T M Cocks; J D Moffatt
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

2.  Proteolysis and phosphorylation-mediated regulation of thrombin receptor activity in in situ endothelial cells.

Authors:  O Mizuno; K Hirano; J Nishimura; C Kubo; H Kanaide
Journal:  Eur J Pharmacol       Date:  2000-02-11       Impact factor: 4.432

Review 3.  Measurement of [Ca2+]i in smooth muscle strips using front-surface fluorimetry.

Authors:  H Kanaide
Journal:  Methods Mol Biol       Date:  1999

Review 4.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

Review 5.  Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

Authors:  O Déry; C U Corvera; M Steinhoff; N W Bunnett
Journal:  Am J Physiol       Date:  1998-06

6.  Enhanced contractile response to thrombin in the pregnant rat myometrium.

Authors:  Y Shintani; K Hirano; J Nishimura; H Nakano; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.

Authors:  D Loew; C Perrault; M Morales; S Moog; C Ravanat; S Schuhler; R Arcone; C Pietropaolo; J P Cazenave; A van Dorsselaer; F Lanza
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

8.  Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail.

Authors:  S R Hammes; M J Shapiro; S R Coughlin
Journal:  Biochemistry       Date:  1999-07-20       Impact factor: 3.162

9.  A dual thrombin receptor system for platelet activation.

Authors:  M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

10.  Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries.

Authors:  J R Hamilton; P B Nguyen; T M Cocks
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

View more
  5 in total

1.  Impaired feedback regulation of the receptor activity and the myofilament Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Katsuharu Kameda; Mayumi Hirano; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

2.  N-linked glycosylation regulates human proteinase-activated receptor-1 cell surface expression and disarming via neutrophil proteinases and thermolysin.

Authors:  Yu Pei Xiao; Alyn H Morice; Steven J Compton; Laura Sadofsky
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

3.  Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro.

Authors:  Peter J O'Brien; Hideki Koi; Samuel Parry; Lawrence F Brass; Jerome F Strauss; Li-Peng Wang; John E Tomaszewski; Lane K Christenson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 4.  Protease Activated Receptor 1 and Its Ligands as Main Regulators of the Regeneration of Peripheral Nerves.

Authors:  Elena Pompili; Valerio De Franchis; Claudia Giampietri; Stefano Leone; Elena De Santis; Francesco Fornai; Lorenzo Fumagalli; Cinzia Fabrizi
Journal:  Biomolecules       Date:  2021-11-10

5.  Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells.

Authors:  Ye Fang; Ann M Ferrie
Journal:  BMC Cell Biol       Date:  2007-06-22       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.